CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 6
Author(s): Kevin Murnane
Affiliation:
Export Options
About this article
Cite this article as:
Murnane Kevin , Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2019; 18 (6) . https://dx.doi.org/10.2174/187152731806190830125346
DOI https://dx.doi.org/10.2174/187152731806190830125346 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
36
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vasculitis Following Influenza Vaccination: A Review of the Literature
Current Rheumatology Reviews The Role of Oxidative Stress in Cerebral Aneurysm Formation and Rupture
Current Neurovascular Research Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD
Current Drug Targets AIDS-related Insulin Resistance and Lipodystrophy Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Commentary (Research Highlights: Transcranial Drug Delivery for Neurological Disorders)
CNS & Neurological Disorders - Drug Targets Dual Inhibition and Monitoring of Beta-Amyloid Fibrillation by a Luminescent Iridium(III) Complex
Current Alzheimer Research Nonviral Approach for Targeted Nucleic Acid Delivery
Current Medicinal Chemistry Differences Between Parkinson’s and Huntington’s Diseases and Their Role for Prioritization of Stem Cell-Based Treatments
Current Molecular Medicine Impact of Alzheimers Disease on the Functional Connectivity of Spontaneous Brain Activity
Current Alzheimer Research Green Tea, A Medicinal Food with Promising Neurological Benefits
Current Neuropharmacology Medicinal Chemistry of Hsp90 Inhibitors
Current Topics in Medicinal Chemistry Stress and the Prodromal Phase of Psychosis
Current Pharmaceutical Design Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life
Current Neurovascular Research Classes of Sigma2 (σ2) Receptor Ligands: Structure Affinity Relationship (SAfiR) Studies and Antiproliferative Activity
Current Pharmaceutical Design An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Medicinal Chemistry Reviews - Online (Discontinued) Cholinergic Drugs as Therapeutic Tools in Inflammatory Diseases: Participation of Neuronal and Non-Neuronal Cholinergic Systems.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Alzheimer Research Modulatory Effects of Peroxisome Proliferator-Activated Receptor-γ on CXCR3 Chemokines
Recent Patents on Inflammation & Allergy Drug Discovery